A Lipid Panel Testing Market is a standard blood test healthcare providers use to monitor and screen the risk of cardiovascular disease and other chronic diseases. The panel includes three measurements of cholesterol and a measurement of triglycerides. While providers healthcare professionals mostly use lipid panels for screening or monitoring cholesterol levels. Providers sometimes use them as part of the diagnostic process for specific health conditions affecting your lipid levels, including pancreatitis, chronic kidney disease, and hypothyroidism.
Get a sample of the report
Thus, in conclusion, the rise in the number of chronic diseases such as cardiovascular diseases, chronic kidney disorders, liver diseases, and various other chronic diseases has led to an increase in the demand for lipid profiling with increasing market demand for lipid panel testing kits will drive the growth of the global lipid panel testing market in coming years.
Data Bridge Market Research analyses that the Global Lipid Panel Testing Market is expected to grow at a CAGR of 7.2% from 2023 to 2030 and reach USD 15,958.03 million by 2030. The rise in the prevalence of dyslipidemia is expected to propel the market’s growth.
In 2023, the services segment is anticipated to dominate the lipid panel testing market.
- On the basis of prescription mode, the global lipid panel testing market is segmented into prescription-based testing and OTC-based testing. In 2023, the prescription based testing segment is expected to dominate the market due to rise in awareness regarding the importance of physician care.
- On the basis of application, the global lipid panel testing market is segmented into hyperlipidemia, hypertriglyceridemia, atherosclerosis, familial hypercholesterolemia, hypo lipoproteinamia, tangier disease, other. In 2023, the hyperlipidemia segment is expected to dominate the market with 28.92% due to the rise in the incidence of hyperlipidemia.
- On the basis of end user, the global lipid panel testing market is segmented into hospitals, specialty clinics and physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others. In 2023, the hospital segment is expected to dominate the market with 25.63% due to the presence of advanced instrumentation, expert surgeons, and facilities for diagnosis through lipid panel testing in the hospital.
- On the basis of distribution channel, the global lipid panel testing market is segmented into direct tender, retail pharmacy, online sales, and others.
Data Bridge Market Research recognizes the following companies as the significant lipid panel testing market players in lipid panel testing market are Nova Biomedical (U.S.), Quest Diagnostics Incorporated. (U.S.) Spark Diagnostics Pvt. Ltd. (U.S.), Everlywell, Inc. (U.S.), HORIBA Medical (Japan), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), SD Biosensor (Republic of Korea), INC., Elitech Group (France), Randox Laboratories Ltd. (U.K.), Diatron (Hungary), Siemens Healthcare GmbH (Germany), Sinocare (China), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Inc., myLAB Box (U.S.), Awareness Technology, Inc. (U.S.), Croda International Plc. (U.S.), Eurofins Scientific (Luxembourg), Boston Heart Diagnostics Corporation (U.S.), cpc diagnostics (India), PTS Diagnostics (U.S.), ARUP Laboratories (U.S.), Laboratory Corporation of America Holdings (U.S.), EKF Diagnostics (Wales), Beckman Coulter, Inc (U.S.). (Subsidiary of Danaher), and Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.) (U.S.) among others.
Asia-Pacific is estimated to be the fastest growing region in lipid panel testing market the forecast period 2023-2030
Asia-Pacific is expected to grow during the forecast period due to increased healthcare facilities with advanced technology and increased e in government funding for research and development to increase test speed and reduce human error.
Access the Full Report @ https://www.databridgemarketresearch.com/reports/global-lipid-panel-testing-market
Browse related reports
Specialty Clinics Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Pharmacy, Online Sales, and Others) https://www.databridgemarketresearch.com/reports/asia-pacific-lipid-panel-testing-market
Middle East and Africa Lipid Panel Testing Market, By Products Services (Devices, Kits, and Services), Prescription Mode (Prescription-Based Testing and OTC-Based Testing), Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo lipoproteinemia, Tangier Disease, Atherosclerosis. and Others), End User (Hospitals, Specialty Clinics Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Pharmacy, Online Sales, and Others) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-lipid-panel-testing-market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research